Back to results
US 2003/0069233 A1Published application
Sulphonamide derivatives, process for their preparation, and their use as medicaments
AssigneeSmithKline Beecham Corporation
InventorsSteven Mark Bromidge, Francis David King, Paul Adrian Wyman
Life of this patent
Estimating the term…
Abstract
Novel sulphonamide derivatives having CNS activity, processes for their preparation and their use as medicaments.
Claims16
A compound of formula (I) or a salt thereof:
- 12
- wherein:
- P is phenyl, naphthyl, a bicyclic heterocyclic ring or is a 5 to 7-membered heterocyclic ring each containing 1 to 4 heteroatoms selected from oxygen, nitrogen or sulphur;
- A is a single bond, a C1-6alkylene or a C1-6alkenylene group;
- R1 is halogen, C1-6alkyl optionally substituted by one or more halogen atoms, C3-6cycloalkyl, COC1-6alkyl, C1-6alkoxy, OCF3, hydroxy, hydroxyC1-6alkyl, hydroxyC1-6alkoxy, acyl, nitro, amino, alkylamino or dialkylamino, cyano or R1 is phenyl, naphthyl, a bicyclic heterocyclic ring or is a 5 to 7-membered heterocyclic ring each containing 1 to 4 heteroatoms selected from oxygen, nitrogen or sulphur;
- n is 0, 1,2,3,4, 5 or 6:
- R2 is hydrogen, C1-6alkyl or aryl C1-6 alkyl;
- R3 is a group R5 or together with R5 forms a group (CH2)2O or (CH2)3O or R3 is linked to R2 to form a group (CH2)2 or (CH2)3;
- R4 is —X(CH2)p—R6 where X is a single bond, CH2, O, NH or N—C1-6-alkyl and p is 0 to 6 and R6 is an optionally substituted 5- to 7-membered heterocyclic ring containing 1 to 3 heteroatoms selected from nitrogen, sulphur or oxygen, or R6 is NR7R8 where R7 and R8 are independently hydrogen, C1-6alkyl or aryl C1-6alkyl;
- and
- R5 is hydrogen, halogen, C1-6alkyl, C3-6cycloalkyl, COC1-6alkyl, C1-6alkoxy, hydroxy, hydroxyC1-6alkyl, hydroxyC1-6alkoxy, C1-6alkoxyC 16alkoxy, acyl, nitro, trifluoromethyl, cyano or aryl.
8 more elements
A process for the preparation of a compound of formula (I) or a salt thereof.
- 13
- wherein:
- P is phenyl, naphthyl, a bicyclic heterocyclic ring or is a 5 to 7-membered heterocyclic ring each containing 1 to 4 heteroatoms selected from oxygen, nitrogen or sulphur;
- A is a single bond, a C1-6alkylene or a C1-6alkenylene group;
- R1 is halogen, C1-6alkyl optionally substituted by one or more halogen atoms, C3-6cycloalkyl, COC1-6alkyl, C1-6alkoxy, OCF3, hydroxy, hydroxyC1-6alkyl, hydroxyC1-6alkoxy, C1-6alkoxyC1-6alkoxy, acyl, nitro, amino, alkylamino or dialkylamino, cyano or R1 is phenyl, naphthyl, a bicyclic heterocyclic ring or is a 5 to 7-membered heterocyclic ring each containing 1 to 4 heteroatoms selected from oxygen, nitrogen or sulphur;
- n is 0,1,2,3,4, 5 or 6:
- R2 is hydrogen, C1-6 alkyl or aryl C1-6 alkyl;
- R3 is a group R5 or together with R5 forms a group (CH2)2O or (CH2)3O or R3 is linked to R2 to form a group (CH2)2 or (CH2)3;
- R4 is —X(CH2)p—R6 where X is a single bond, CH2, O, NH or N—C1-6-alkyl and p is 0 to 6 and R6 is an optionally substituted 5- to 7-membered heterocyclic ring containing 1 to 3 heteroatoms selected from nitrogen, sulphur or oxygen, or R6 is NR7R8 where R7 and R8 are independently hydrogen, C1-6 alkyl or aryl C1-6alkyl;
- and
- R5 is hydrogen, halogen, C1-6alkyl, C3-6cycloalkyl, COC1-6alkyl, C1-6alkoxy, hydroxy, hydroxyC1-6alkyl, hydroxyC1-6alkoxy, C1-6alkoxyC1-6alkoxy, acyl, nitro, trifluoromethyl, cyano or aryl,
- which process comprises the coupling of a compound of formula (II):
- 14
- in which R1, n, P, and A are as defined in formula (I) or protected derivatives thereof and L is a leaving group with a compound of formula (III):
- 15
- in which R2, R3, R4 and R5 are as defined in formula (I) or protected derivatives thereof and optionally thereafter:
- removing any protecting groups,
- forming a pharmaceutically acceptable salt.
15 more elements
Dependencies are inferred from the claim text.